These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24792857)

  • 1. Flushing, fatigue, and recurrent anaphylaxis: a delayed diagnosis of mastocytosis.
    Gülen T; Hägglund H; Dahlén SE; Sander B; Dahlén B; Nilsson G
    Lancet; 2014 May; 383(9928):1608. PubMed ID: 24792857
    [No Abstract]   [Full Text] [Related]  

  • 2. Interactive medical case. A rash hypothesis.
    Ross JJ; Saavedra A; Vleugels RA; Liu A; Castells MC
    N Engl J Med; 2010 Jun; 362(24):e69. PubMed ID: 20560180
    [No Abstract]   [Full Text] [Related]  

  • 3. Refractory symptoms successfully treated with leukotriene inhibition in a child with systemic mastocytosis.
    Turner PJ; Kemp AS; Rogers M; Mehr S
    Pediatr Dermatol; 2012; 29(2):222-3. PubMed ID: 22044360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. INTERACTIVE MEDICAL CASE. A Stinging Sensation.
    Lee-Sarwar K; Vaidya A; Shi M; Akin C
    N Engl J Med; 2015 Jun; 372(26):e35. PubMed ID: 26107069
    [No Abstract]   [Full Text] [Related]  

  • 5. Leukotriene-receptor inhibition for the treatment of systemic mastocytosis.
    Tolar J; Tope WD; Neglia JP
    N Engl J Med; 2004 Feb; 350(7):735-6. PubMed ID: 14960756
    [No Abstract]   [Full Text] [Related]  

  • 6. Premedication with montelukast reduces local reactions of allergen immunotherapy.
    Wöhrl S; Gamper S; Hemmer W; Heinze G; Stingl G; Kinaciyan T
    Int Arch Allergy Immunol; 2007; 144(2):137-42. PubMed ID: 17536222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential diagnosis of the patient with unexplained flushing/anaphylaxis.
    Metcalfe DD
    Allergy Asthma Proc; 2000; 21(1):21-4. PubMed ID: 10748948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of telangiectasia macularis eruptiva perstans with montelukast.
    Cengizlier R; Hücümenoğlu S; Ozen A; Tülin Sayli R
    Allergol Immunopathol (Madr); 2009; 37(6):334-6. PubMed ID: 19913347
    [No Abstract]   [Full Text] [Related]  

  • 9. Recurrent syncope and anaphylaxis as presentation of systemic mastocytosis in a pediatric patient: case report and literature review.
    Shaffer HC; Parsons DJ; Peden DB; Morrell D
    J Am Acad Dermatol; 2006 May; 54(5 Suppl):S210-3. PubMed ID: 16631942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of montelukast to prevent anaphylaxis to diclofenac.
    Enrique E; García-Ortega P; Gaig P; San Miguel MM
    Allergy; 1999 May; 54(5):529-30. PubMed ID: 10380791
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.
    Nayak AS; Philip G; Lu S; Malice MP; Reiss TF;
    Ann Allergy Asthma Immunol; 2002 Jun; 88(6):592-600. PubMed ID: 12086367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose desloratadine and montelukast and allergen-induced late airway responses.
    Davis BE; Illamperuma C; Gauvreau GM; Watson RM; O'Byrne PM; Deschesnes F; Boulet LP; Cockcroft DW
    Eur Respir J; 2009 Jun; 33(6):1302-8. PubMed ID: 19164343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.
    Meltzer EO; Malmstrom K; Lu S; Prenner BM; Wei LX; Weinstein SF; Wolfe JD; Reiss TF
    J Allergy Clin Immunol; 2000 May; 105(5):917-22. PubMed ID: 10808172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic options in idiopathic chronic urticaria].
    Mora PM; González Pérez Mdel C; Jiménez Villarruel M; Rodriguez Castro E; Fogelbach GG
    Rev Alerg Mex; 2005; 52(2):77-82. PubMed ID: 16158780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systemic mastocytosis].
    Sade K; Dotan I; Levo Y
    Harefuah; 2000 Sep; 139(5-6):202-6, 245. PubMed ID: 11062953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluticasone nasal spray and the combination of loratadine and montelukast in seasonal allergic rhinitis.
    Saengpanich S; deTineo M; Naclerio RM; Baroody FM
    Arch Otolaryngol Head Neck Surg; 2003 May; 129(5):557-62. PubMed ID: 12759270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
    Moinuddin R; deTineo M; Maleckar B; Naclerio RM; Baroody FM
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant activity of histamine and cysteinyl leukotrienes on porcine nasal mucosal vessels and nasal inflammation in the rat.
    Lieber G; Jimenez J; Hunter JC; McLeod RL; Jia Y
    Pharmacology; 2010; 85(5):311-8. PubMed ID: 20453555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.
    Di Lorenzo G; Pacor ML; Mansueto P; Esposito Pellitteri M; Lo Bianco C; Ditta V; Martinelli N; Rini GB
    J Allergy Clin Immunol; 2004 Sep; 114(3):619-25. PubMed ID: 15356567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast Cells, Mastocytosis, and Related Disorders.
    Theoharides TC; Valent P; Akin C
    N Engl J Med; 2015 Jul; 373(2):163-72. PubMed ID: 26154789
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.